These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22555323)

  • 1. Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies.
    Tragiannidis A; Dokos C; Tsotoulidou V; Giannopoulos A; Pana ZD; Papageorgiou T; Karamouzis M; Athanassiadou F
    Minerva Pediatr; 2012 Jun; 64(3):307-12. PubMed ID: 22555323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated B-type natriuretic peptide levels after anthracycline administration.
    Suzuki T; Hayashi D; Yamazaki T; Mizuno T; Kanda Y; Komuro I; Kurabayashi M; Yamaoki K; Mitani K; Hirai H; Nagai R; Yazaki Y
    Am Heart J; 1998 Aug; 136(2):362-3. PubMed ID: 9704703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.
    Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T
    Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
    Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
    Feola M; Garrone O; Occelli M; Francini A; Biggi A; Visconti G; Albrile F; Bobbio M; Merlano M
    Int J Cardiol; 2011 Apr; 148(2):194-8. PubMed ID: 19945181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
    Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
    Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic stress echocardiography in asymptomatic patients who received chemotherapy in childhood because of a malignant disease.
    Elbl L; Hrstkova H; Chaloupka V; Michalek J
    Kardiol Pol; 2003 Mar; 58(3):190-6. PubMed ID: 14513093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of anthracycline induced cardiotoxicity.
    Erkus B; Demirtas S; Yarpuzlu AA; Can M; Genc Y; Karaca L
    Acta Paediatr; 2007 Apr; 96(4):506-9. PubMed ID: 17391467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
    Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP
    In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
    J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of B-type natriuretic peptide in paediatric patients: a review of literature.
    Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.